(continued)
- FDA OKs New Monthly Treatment for Rare Swelling Disorder
- More Adults Can Now Get Moderna's RSV Shot
- FDA OKs New Next-Gen Pill for Rare Lung Cancer
- FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
- FDA OKs New Shot to Protect Babies Against RSV
- FDA Approves Moderna’s New COVID Vaccine With Restricted Use
- FDA OKs First Meningococcal Vaccine for Infants
- FDA Approves New Treatment for Dry Eye Disease
- FDA OKs Nucala for Hard-to-Treat COPD
- FDA Approves Novavax COVID Vaccine With Restricted Use
- FDA OKs New Treatment for Hard-to-Treat Lung Cancer
- FDA Approves New Oral Drug Combo for Rare Ovarian Cancer
- FDA Approves New Long-Term Treatment for Myasthenia Gravis
- FDA Approves New Gene Therapy for Rare Genetic Skin Disorder
- FDA OKs New Drug for Rare Head and Neck Cancer
- FDA Approves Dupixent for Chronic Skin Condition
- FDA Approves New Treatment for Serious Kidney Disorder
- New Hemophilia Treatment Wins FDA Approval
- FDA OKs Drug for Insatiable Hunger in Prader-Willi Syndrome
- FDA Green-Lights First New Antibiotic for UTIs in Nearly 30 Years
- FDA OKs Novel Treatment for Life-Threatening Heart Condition
- FDA OKs New Crohn’s Treatment You Can Inject at Home
- FDA OKs First Treatment for Rare Kidney Disease
- FDA OKs First Myasthenia Gravis Treatment for Children
- FDA OKs First Gene Therapy Implant for a Rare Eye Disease
- FDA OKs Nasal Spray for Severe Allergic Reactions in Kids
- FDA Approves New Treatment for Stroke
- FDA Approves New Label for Opioid Use Disorder Drug
- FDA Approves New Treatment for Rare Lipid Storage Disease
- FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes